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TISSUE ENGINEERED BONE GRAFT SUBSTITUTE
*Sylvester, S; *Norman, TL; +*Mukherjee, N
*West Virginia University, Morgantown, WV

Methods: Bone marrow was isolated from adult male New Zealand
white rabbit femurs. They were expanded in monolayer culture adapted
from standard protocols developed for rat models (2) (3). The fastest
growing cells were selected for further experiments.
Well-plate: Approximately 5x10 4 cells were placed in each
treatment well of a 24 well plate and exposed to one of three treatments:
Minimum essential medium (MEM), 40ng/mL Dexamethasone and
MEM or 50ng/mL BMP-2, 40ng/mL Dexamethasone and MEM. The
non-control treatments were given additional mineralizing agents of
2.8x10 -4M concentration of L-ascorbic acid and 10mM concentration of
β-glycerophosphate starting on day 7 and every media change thereafter
(4) (5). The media was changed every three days.
Wells were stained with alkaline phosphatase staining kit
(Sigma, St. Louis, MO) to determine the activity of the alkaline
phosphatase enzyme, an early indicator of osteogenesis (6) and von
Kossa (7), which indicates mineralization, a late stage of osteogenesis
Healos: Healos matrix was cut into 4mm squares and placed
into sterile 24 well plates. 2.5x106 bone marrow derived cells suspe nded
in 0.2ml of MEM media were added to the Healos mesh. After allowing
2 hours for the cells to attach, culture media was added. 40ng/ml
Dexamethasone was used as an osteoinductive agent (8). The different
groups were: Healos matrix alone and Healos matrix + cells. Media was
changed every 3 days. After 1 and 2 weeks in culture, the constructs
were fixed in 10% neutral buffered formalin, processed for histology and
stained with Hematoxylin and Eosin (H&E) and Von Kossa.
Essential Results:
Well-plate: ANOVA analysis showed that some groups were
significantly different from others [F=0.0023 at p=0.05 level] in terms of
alkaline phosphatase activity. The trend in the data showed that alkaline
phosphatase activity increased over a three-week period with a decline
in activity seen at week 4 (Figure 1). Von Kossa staining was not
observed at week 1 – 3 sampling time points. Week 4 showed a positive
stain for Von Kossa (Figure 2) with the MEM+BMP-2+Dexa treatment
having the largest percent area coverage [p=0.001].
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Introduction: Tissue engineering products are recognized for their
potential as treatment alternatives for repairing/regenerating tissue lost
due to trauma or degeneration, or to correct congenital malformations.
The goal is to restore organ function (1). Our tissue engineering strategy
to generate bone follows the paradigm of implanting osteogenic cells in
a scaffold material that will temporarily support the cells until they can
form bone. In this study we isolated cells from bone marrow of New
Zealand white rabbits and tested their osteogenic potential in various
culture conditions. We then embedded these cells in a commercially
available mineralized collagen matrix (Healos from Orquest, Mountain
View, Ca) and assessed the ability of these cells to populate the matrix
and form bone like tissue in vitro. The overall goal of this research is to
develop alternatives to autologous bone graft substitutes for procedures
such as posterolateral spinal fusion. If successful, the findings may
eventually lead to enhanced healing and reduce morbidity associated
with autologous bone grafting.
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Fig 2: Von Kossa staining was not observed through day 21 but
appeared at day 28. Treatment groups showed significantly higher
mineralization than controls on day 28 [p=0.001]
Healos: The cells appeared to survive in the Healos mesh.
The media changed color signifying that the cells were metabolically
active. Some cells seemed to migrate from the mesh and populated the
bottom of the dish. The H &E staining showed that at two weeks, many
cells attached to the mesh and were able to deposit extra-cellular matrix
around them. The Von Kossa staining showed that the matrix had not yet
mineralized at 2 weeks, as expected (Figure 3a,b).
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Fig 3: After 2 weeks in culture, the rabbit bone marrow derived cells
(nuclei stained blue, indicated by arrows) populated the matrix, which
stained pink, indicated by arrow heads (A). The cells are able to lay
down matrix around them (faint pink). B) Under Von Kossa staining, the
Healos matrix stains black while the extracellular matrix deposited by
the cells is apparent but not mineralized.
Discussion: This work showed that we were able to isolate precursor
cells from bone marrow that could be induced to differentiate down the
osteogenic pathway in vitro, as shown by alkaline phosphatase activity
and von Kossa staining. These cells were able to populate the healos
mesh and lay down extracellular matrix around them. Since the Healos
is bovine collagen coated with hydroxyapatite, it also stained positive for
Von Kossa and it will be hard to tell if the cells deposited mineralized
matrix at time points greater than 2 weeks. These results have
encouraged us to use this tissue engineering construct as a bone graft
substitute in a rabbit posterolateral spinal fusion model.
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Fig 1: Alkaline Phosphatase enzyme activity increased through day 21
and declined later [F=0.002 at p=0.05 level].
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